Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Mason Heather L | Nov 18, 2024 | Buy | 75,000 | $0.8 | $60,000 |
| O'Grady Brendan P. | Nov 14, 2024 | Buy | 11,706 | $0.85 | $10,000 |
| Vacirca Jeff L | Jun 11, 2024 | Buy | 10,000 | $1.11 | $11,000 |
| Mason Heather L | Jun 5, 2024 | Buy | 25,000 | $0.97 | $24,000 |
| Tyree James L | Mar 14, 2024 | Sell | 10,251 | $1.1182 | $11,000 |
| Peisert Daniel A. | Sep 12, 2023 | Sell | 31,121 | $2.9701 | $92,000 |
| Schwichtenberg Paul | Sep 11, 2023 | Sell | 104,980 | $3.0729 | $320,000 |
| Peisert Daniel A. | Sep 11, 2023 | Sell | 127,281 | $3.0403 | $390,000 |
| Schlessinger Sam | Sep 11, 2023 | Sell | 45,236 | $3.0383 | $140,000 |
| Patel Ajay | Sep 11, 2023 | Sell | 64,313 | $3.0444 | $200,000 |
| MCKEE WILLIAM | Aug 14, 2023 | Sell | 22,000 | $3.1384 | $69,000 |
| Mason Heather L | May 19, 2023 | Sell | 89,286 | $7.3025 | $650,000 |
| Tyree James L | May 5, 2023 | Sell | 43,143 | $5.9979 | $260,000 |
What's the latest insider transaction for Assertio Therapeutics?
The most recent insider transaction for Assertio Therapeutics was conducted by Mason Heather L, who sold 75,000 shares on November 18, 2024 at a price of $0.80 per share.
Which insider bought the most ASRT stock over the last two years?
Mason Heather L has bought the most ASRT stock in the last 2 years, with a total value of $84,000.
Which insider has sold the most ASRT stock over the last two years?
Mason Heather L has sold the most ASRT stock in the last 2 years, with a total value of $650,000.
What is the total value of insider transactions for Assertio Therapeutics (ASRT) in the last 2 years?
The total value of insider transactions for Assertio Therapeutics in the last 2 years is negative, amounting to -$2M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Assertio Therapeutics' market confidence?
Over the last 2 years, insider transactions for Assertio Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
